Drug Addiction vs Drug Dependence: What’s the Difference?

drug addiction vs dependence

Introduction: Two Terms That Mean Different Things

“Drug addiction” and “drug dependence” are used interchangeably in everyday conversation — by families, journalists, politicians, and even many healthcare workers. The assumption is that they describe the same thing, simply using different words.

They do not.

The distinction between addiction and dependence is clinically meaningful, practically important, and increasingly central to how substance use disorders are understood, diagnosed, and treated. Getting it wrong leads to misdiagnosis, stigma, and treatment decisions that do not match the clinical reality.

This article explains what each term means, how they differ, why the distinction matters, and how both concepts have evolved in clinical language over recent decades — including what the current gold-standard diagnostic framework, the DSM-5, actually says.

If you want to understand the broader picture of how and why addiction develops, our pillar on why addiction happens: trauma, stress, and mental health covers the root causes in depth.

How These Terms Have Been Used Historically

For much of the twentieth century, clinical frameworks separated substance use problems into two categories:

Substance abuse — a pattern of use causing significant harm or impairment (social, legal, occupational) without the presence of tolerance or withdrawal symptoms. The implication was that the person was using recklessly or irresponsibly, but was not physiologically dependent.

Substance dependence — a more severe pattern that included physiological adaptation to the substance: tolerance (needing more to achieve the same effect) and withdrawal (physical symptoms when use stopped or reduced).

In this older framework — enshrined in the DSM-IV — dependence was the more serious diagnosis, associated with physical addiction, while abuse was considered a less severe pattern.

The problem was that this framework conflated physical dependence with addiction. And those are genuinely different things.

What Physical Dependence Actually Means

Physical dependence refers to a physiological state in which the body has adapted to the regular presence of a substance and responds to its removal with withdrawal symptoms. It is a neurobiological process — the nervous system has reorganised itself to function with the substance present, and requires time to readjust when it is absent.

Physical dependence can occur with many substances, including ones we would not ordinarily describe as addictive. Clear examples in clinical practice:

Antidepressants (SSRIs and SNRIs) — Many people taking antidepressants experience discontinuation syndrome when stopping — symptoms including dizziness, nausea, “brain zaps,” irritability, and mood changes. This is physical dependence. The person’s brain has adapted to the presence of the medication. But they are not addicted to their antidepressants.

Beta-blockers — Used for blood pressure and heart conditions, abrupt cessation can cause rebound hypertension and cardiovascular events. Physical dependence, not addiction.

Corticosteroids — Long-term steroid use produces adrenal suppression; abrupt withdrawal can cause serious medical complications. Physical dependence, not addiction.

Opioid pain medications — Someone prescribed opioids for chronic pain who takes their medication exactly as directed and has never misused it may develop physical dependence — withdrawal symptoms if they stop suddenly. They are not necessarily addicted.

Benzodiazepines — Prescribed appropriately for anxiety or sleep disorders, often producing significant physical dependence that requires careful medical tapering to cease safely. Physical dependence does not equal addiction.

Physical dependence is a pharmacological consequence of regular use of certain substances. It can occur in anyone who takes particular medications regularly, regardless of their relationship with those substances.

What Addiction Actually Means

Addiction — now formally termed Substance Use Disorder (SUD) in the DSM-5 — is a fundamentally different concept. It describes a complex behavioural pattern characterised by:

  • Impaired control over use — using more than intended, unsuccessful attempts to cut back, spending significant time obtaining and using
  • Compulsive use despite harm — continuing to use despite clear evidence it is causing physical, psychological, social, or occupational damage
  • Craving — strong, often intrusive urges to use
  • Reorganisation of priorities — substance use becoming the central organising principle of daily life at the expense of other values, relationships, and responsibilities

Addiction involves neurobiological changes — particularly to the prefrontal cortex (impairing executive control) and the reward and stress systems — but it is not reducible to those changes. It encompasses the psychological, behavioural, and social dimensions of compulsive substance use in a way that physical dependence does not.

The critical distinction: Physical dependence is about the body’s physiological adaptation to a substance. Addiction is about the compulsive, harmful, loss-of-control relationship with a substance.

You can have physical dependence without addiction. You can have addiction without significant physical dependence. And most people with substance use disorders have elements of both.

What the DSM-5 Changed — and Why It Matters

In 2013, the publication of the DSM-5 (Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition) fundamentally revised how substance use problems are classified.

The DSM-5 eliminated the separate categories of “substance abuse” and “substance dependence” entirely. In their place, it introduced a single diagnostic category — Substance Use Disorder (SUD) — classified on a spectrum from mild to severe based on the number of diagnostic criteria met within a 12-month period.

The 11 DSM-5 criteria for Substance Use Disorder span four domains:

Impaired control:

  1. Taking the substance in larger amounts or for longer than intended
  2. Persistent desire or unsuccessful efforts to cut down
  3. Spending a great deal of time obtaining, using, or recovering from the substance
  4. Craving

Social impairment: 5. Failure to fulfil major role obligations at work, school, or home 6. Continued use despite persistent social or interpersonal problems caused or worsened by use 7. Giving up important activities because of substance use

Risky use: 8. Recurrent use in physically hazardous situations 9. Continued use despite knowledge of a persistent physical or psychological problem caused or worsened by the substance

Pharmacological criteria: 10. Tolerance 11. Withdrawal

Meeting 2–3 criteria constitutes mild SUD. 4–5 is moderate. 6 or more is severe.

Critically, tolerance and withdrawal (the pharmacological criteria — criteria 10 and 11) are only two of eleven criteria. They are relevant, but they are not the defining features of a substance use disorder. Someone can meet the clinical threshold for SUD without experiencing significant physical withdrawal.

This is a significant departure from the older framework, which placed physical dependence at the centre of the most serious diagnosis. The DSM-5 recentres the diagnosis on the behavioural and psychological dimensions of impaired control and continued use despite harm.

One important exception noted in the DSM-5: Tolerance and withdrawal that occur solely as a result of prescribed medication use — where there is no underlying misuse or compulsive use pattern — do not count toward a SUD diagnosis. This reflects the distinction between physical dependence and addiction in practice.

Why the Distinction Matters: Three Practical Implications

1. For People Taking Prescribed Medications

Many Australians taking medications for pain, anxiety, sleep, or other conditions worry that their physical dependence on those medications constitutes addiction. In most cases, it does not. Physical adaptation to a prescribed medication — taken as directed, not escalated beyond prescription, not associated with craving or compulsive use — is a pharmacological process, not a behavioural disorder.

This matters enormously for reducing stigma and for supporting people to be honest with their healthcare providers. A person who is afraid they are “an addict” because they cannot stop their prescribed opioids without withdrawal may avoid discussing this with their GP — which delays appropriate tapering support and, paradoxically, increases risk.

2. For Assessment and Diagnosis

The DSM-5 framework means that diagnosis is not determined primarily by the presence of withdrawal or tolerance. It is determined by the overall pattern of use — the loss of control, the harm, the compulsion, the reorganisation of life around the substance.

This means someone who has developed a compulsive, harmful relationship with cocaine — a substance that does not typically produce significant physical dependence — still meets criteria for Substance Use Disorder. And someone taking opioids for chronic pain who has developed physical dependence but is using them appropriately under medical supervision may not meet criteria at all.

For more on recognising when substance use has crossed the clinical threshold, see our article on signs someone needs professional rehab.

3. For Treatment Planning

The distinction between physical dependence and addiction has direct implications for treatment:

Physical dependence requires medical management — careful tapering, supervised withdrawal, monitoring for medical complications. For alcohol and benzodiazepines in particular, abrupt cessation can be dangerous. This is a medical problem, addressed through medical means.

Addiction (SUD) requires psychological, behavioural, and social treatment — evidence-based therapies including CBT and DBT, trauma-informed care, peer support, and structured continuing care. These address the compulsive patterns, the underlying drivers, and the life domains affected. This is a complex biopsychosocial problem, addressed through comprehensive, integrated treatment.

Most people with moderate to severe SUD need both. But conflating the two leads to incomplete treatment — where the medical aspect is managed but the psychological and behavioural dimensions are not addressed, or vice versa.

HARP’s three-pronged clinical model — integrating an Addiction Specialist, Trauma Specialist Psychologist, and AOD Specialist Counsellor — is designed precisely to address both the neurobiological dimensions (where physical dependence fits) and the behavioural, psychological, and trauma-driven dimensions of Substance Use Disorder simultaneously. Read more: dual diagnosis and addiction recovery.

A Note on Language and Stigma

The language used to describe substance use problems carries significant clinical and social weight. The word “addict” — while commonly used — is increasingly avoided in clinical practice in favour of person-first language: “a person with a substance use disorder,” “a person in recovery,” “someone experiencing problematic alcohol use.”

This is not political correctness. It reflects a clinical position: addiction is a health condition, not an identity or a character conclusion. Labelling someone an “addict” implicitly frames the problem as intrinsic to the person rather than as a treatable condition they are experiencing.

The Australian Government’s Department of Health and Aged Care, the AIHW, and the Alcohol and Drug Foundation (ADF) all promote person-first language in AOD contexts — and the clinical evidence suggests it improves engagement, reduces shame, and supports better treatment outcomes.

Similarly, the shift from “dependence” to “Substance Use Disorder” in the DSM-5 was partly motivated by the desire to reduce stigma — to describe what is actually happening clinically (a disorder of behaviour and neurobiology) rather than language that implies moral failing or irreversible pathology.

Frequently Asked Questions

Can you be physically dependent on alcohol without being addicted? In principle, yes — though it is uncommon at clinically significant levels of physical dependence. Someone who has been prescribed alcohol as part of a medical protocol (extremely rare) or who has developed physical dependence through heavy but brief use may experience withdrawal without meeting the broader DSM-5 criteria for Alcohol Use Disorder. In practice, significant physical alcohol dependence is almost always accompanied by the behavioural and psychological features of addiction. If you are experiencing alcohol withdrawal symptoms when not drinking, speak to your GP — this always warrants medical assessment.

Does having a high tolerance mean you are addicted? Tolerance — needing more of a substance to achieve the same effect — is one of the 11 DSM-5 criteria for Substance Use Disorder, but meeting only one criterion does not constitute a diagnosis (two or more are required). Tolerance can develop through regular use of many substances without the broader pattern of impaired control and harm that defines addiction. However, escalating tolerance is a clinical signal worth paying attention to, particularly when combined with other changes in how and why you use.

Is addiction a disease or a choice? The current clinical and scientific consensus — reflected in the positions of NIDA, the AMA, the ADF, and the World Health Organization — is that addiction is a chronic brain disorder influenced by genetic, neurobiological, psychological, and environmental factors. This does not eliminate personal agency or responsibility in recovery. What it does is recognise that the neurobiological changes produced by addiction impair the very brain systems responsible for choice and self-regulation — which is why treatment, not willpower alone, is the effective response.

If I stop using without withdrawal symptoms, does that mean I was not really addicted? Not necessarily. Absence of significant physical withdrawal does not rule out a Substance Use Disorder. Many substances — including cocaine and cannabis — do not produce the dramatic physical withdrawal associated with alcohol or opioids, but can produce significant psychological withdrawal (cravings, mood changes, sleep disruption) and are associated with genuine addiction. The DSM-5 diagnosis is based on the full 11-criteria pattern, not withdrawal alone.


Sources

  1. American Psychiatric AssociationDiagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) (2013)
  2. NIDA — The Science of Drug Use and Addiction: The Basics
  3. Alcohol and Drug Foundation (ADF)Understanding Dependence and Addiction
  4. AIHWAlcohol and Other Drug Treatment Services in Australia, 2022–23
  5. Koob GF & Volkow ND — “Neurobiology of addiction: a neurocircuitry analysis,” The Lancet Psychiatry (2016)
  6. Australian Government Department of Health and Aged CareLanguage Guide: Alcohol and Other Drugs
  7. World Health Organization (WHO)Lexicon of Alcohol and Drug Terms
  8. National Alcohol and Other Drug Hotline — 1800 250 015 (free, confidential, 24/7)

This article is reviewed for clinical accuracy and is intended for educational purposes only. It does not constitute medical advice. Please consult your GP or a qualified AOD specialist for personalised guidance.

MEET THE AUTHOR

Joshua Theodore

Intake Officer

As Head of Admissions at HARP, Josh Theodore leads the intake experience with a focus on discretion, clarity, and trust. He works closely with individuals, families, and referring professionals to ensure every client journey begins with a thorough understanding of needs, goals, and circumstances. Josh oversees the admissions process end-to-end, providing clear communication, timely coordination, and a highly personalised approach that reflects HARP’s commitment to clinical excellence and compassionate care.

In addition to client engagement, Josh manages strategic partnerships across a broad professional network, including psychologists, human resource departments, legal professionals, and other C-suite specialists. He acts as a key liaison between HARP and its referral partners, ensuring alignment, ethical integrity, and seamless collaboration. Through these relationships, Josh strengthens HARP’s multidisciplinary ecosystem, supporting integrated outcomes for clients while maintaining the highest standards of professionalism and confidentiality.

MORE ABOUT THE AUTHOR
Speak to a Specialist | No Waitlist